Embracing Decentralized Trials Is Not ‘Plug And Play’
Executive Summary
Trial sponsors are proactively seeking opportunities to incorporate decentralized elements into their studies, but the lack of regulatory guidance makes it a difficult exercise.
You may also be interested in...
EU Decentralized Trials Guide Due Early In 2022
The upcoming EU guideline on decentralized clinical trials is the result of a “learning by doing” exercise and builds on various pilots and initiatives launched by different member states.
Sweden Tackles Regulatory Barriers To Decentralized Trials
The COVID-19 pandemic has given a new impetus to Sweden’s ongoing efforts to support decentralized clinical trials.
Switzerland Supports ‘Increasingly Important’ Decentralized Clinical Trials
A new position paper outlines several factors that sponsors must consider when planning to undertake decentralized clinical trials in Switzerland to ensure compliance with national legal and ethics requirements.